1
40
2
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://www.sciencedirect.com/science/article/pii/S0885392401003402" target="_blank" rel="noreferrer">http://www.sciencedirect.com/science/article/pii/S0885392401003402</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
“Burst” ketamine for refractory cancer pain: an open-label audit of 39 patients
Publisher
An entity responsible for making the resource available
Journal Of Pain And Symptom Management
Date
A point or period of time associated with an event in the lifecycle of the resource
2001
Creator
An entity primarily responsible for making the resource
Jackson K; Ashby M; Martin P; Pisasale M; Brumley D; Hayes Barbara
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
Description
An account of the resource
2001
2001
Ashby M
Backlog
Brumley D
Hayes Barbara
Jackson K
Journal Article
Journal of Pain and Symptom Management
Martin P
Pisasale M
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1016/S0885-3924(01)00340-2" target="_blank" rel="noreferrer">http://doi.org/10.1016/S0885-3924(01)00340-2</a>
<a href="http://www.sciencedirect.com/science/article/pii/S0885392401003402" target="_blank" rel="noreferrer">http://www.sciencedirect.com/science/article/pii/S0885392401003402</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
“Burst” Ketamine for Refractory Cancer Pain: An Open-Label Audit of 39 Patients Kate Jackson, MB BS, DTM&H, FRCA, FAChPM, Michael Ashby, MB
Publisher
An entity responsible for making the resource available
Journal Of Pain And Symptom Management
Date
A point or period of time associated with an event in the lifecycle of the resource
2001
Creator
An entity primarily responsible for making the resource
Jackson K; Ashby M; Martin P; PallMed Dip; Pisasale M; Brumley D; Hayes B
Description
An account of the resource
The results of a novel approach to the use of ketamine in refractory cancer pain are reported. In this prospective, multicenter, unblinded, open-label audit, 39 patients (with a total of 43 pains) received a short duration (3 to 5 days) ketamine infusion. The initial dose of 100 mg/ 24 hr was escalated if required to 300 mg/24 hr and then to a maximum dose of 500 mg/ 24hr. The overall response rate was 29/43 (67%). Analysis of results according to pain mechanisms showed that 15/17 somatic and 14/23 neuropathic pains responded. In 5 patients who appeared to respond, it is possible that another concurrent intervention may have contributed in whole or part for the pain relief observed. After cessation of ketamine, 24/29 maintained good pain control, with a maximum documented duration of eight weeks. However, 5 of the initial 29 responders experienced a recurrence of pain within 24 hours, and ketamine was recommenced. Of these, 2 underwent another intervention for pain control while 3 continued on ketamine until their deaths between two and four weeks later. Twelve patients reported adverse psychomimetic effects, with the incidence rising with increasing dose. Four of these were non-responders and the ketamine was stopped. Eight were responders, and in 3 the adverse effects were rendered acceptable with dose reduction; the other 5 rejected a dose reduction. The results reported suggest the need for further investigation of the place of ketamine in cancer pain management.
2001-10
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/S0885-3924(01)00340-2" target="_blank" rel="noreferrer">10.1016/S0885-3924(01)00340-2</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2001
Ashby M
Backlog
Brumley D
Hayes B
Jackson K
Journal Article
Journal of Pain and Symptom Management
Martin P
PallMed Dip
Pisasale M